Baker Pharmaceuticals

Revision as of 22:53, 21 August 2011 by CungrVanck (talk | contribs)

Baker Pharmaceuticals is a pharmaceutical company in the Lyran Commonwealth.[1]

Company Profile

Commonwealth Stock Exchange Symbol: BakPhar

Home Office: New Benner, Baker 3

President/CEO: John Sleeth

Baker Pharmaceuticals has been in business with the Lyran Commonwealth for many years. In 3023, the company paid a 300 million credit lawsuit when a batch of their synthetic antibodies went toxic and killed over 100 soldiers of the LCAF. To prevent a takeover of the company by Nashsan Diversified, the company president, John Sleeth, authorized the buy back of all public owned stock at a higher price than Nashsan was offering. This has led the company to cut costs, staff and operations. As of 3025, the company has been faced with many problems and many wonder if it will survive the year.

References

  1. House Steiner (The Lyran Commonwealth), p. 142, "Other Major Commonwealth Industries"

Bibliography